January 2022 FDA Recall Drug by Pharmasol Corporation
D-0574-2022 - cGMP deviations

This Class II drug recall was voluntarily initiated by Pharmasol Corporation on January 11, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed to a client in Colorado. and the recall is currently terminated.

Recall Number: D-0574-2022

Reason for Recall
cGMP deviations
Initiated
01-11-2022
Reported
03-02-2022
Quantity
5,004 cans of propellent

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
89635
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Pharmasol Corporation
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Product was distributed to a client in Colorado.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2023
Product Description About Product Description
Full technical description of the product.
Lung Cleaner (saline eucalyptus) inhaler, 37 oz cans, Manufactured For: The Lung Cleaner LLC Boulder, CO 80302

Batch or Lot Expiration Information

Lot# : 33748